Percent emphysema, airflow obstruction, and impaired left ventricular filling. - sprookjes - yvandenbroek - TriplyDB

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

http://www.wikidata.org/entity/Q33921323

about

Occupational risk factors for COPD phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) lung study Physiological impairment in mild COPD Advances in the epidemiology of heart failure and left ventricular remodeling Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging Right ventricular dysfunction in chronic lung disease Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction Particulate Matter Exposure and Cardiopulmonary Differences in the Multi-Ethnic Study of Atherosclerosis Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.Air pollution and percent emphysema identified by computed tomography in the Multi-Ethnic study of Atherosclerosis.Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA Lung Study Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study The association of systemic microvascular changes with lung function and lung density: a cross-sectional study Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)Right ventricular morphology and the onset of dyspnea: the MESA-right ventricle study Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study)Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients Lung Function, Percent Emphysema, and QT Duration: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study.Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia Epidemiology, pathophysiology, and prognosis of heart failure in the elderly.Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD Epidemiology and clinical impact of major comorbidities in patients with COPD.What Limits Cardiac Performance during Exercise in Normal Subjects and in Healthy Fontan Patients?Serial pulmonary function tests to diagnose COPD in chronic heart failure Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial Socioeconomic status is positively associated with percent emphysema on CT scan: The MESA lung study Quantitative computed tomography of pulmonary emphysema and ventricular function in chronic obstructive pulmonary disease patients with pulmonary hypertension.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction

P2860

Q23910516-C91B8354-22E5-4F19-B820-E0C0B7E669CF Q26786480-D0DF1202-05A8-4420-9F40-F6B0F9FCD038 Q26827147-24D06296-8BE3-42A6-89A0-768687348C4A Q26861010-934FAD06-0BBA-489D-876E-0BB3BC08AFE5 Q27002670-B96C2D3B-2605-4190-9CE9-186B3B584B02 Q28073079-B75BC322-6C9D-477D-AE21-4AE1521124EC Q28386060-D5E80999-2E3A-49A4-8D4A-6AF0A28AC9D5 Q28386977-3A65A388-FCA7-4B4C-A0ED-D29C3A466F3A Q28387051-D77F497F-4B0A-42F2-9EDF-5FE2E8DB466F Q28387179-E2399C35-C5DF-4168-A30D-C280599CDC6B Q28388015-44630FA9-28D9-4492-9B13-A9E2DB01A345 Q28388122-E29AFB89-B874-448C-A55D-4CD872334F41 Q28389082-CD0BA309-58A6-4166-8954-4E4AEC069EFC Q28390489-5542BD96-038A-43D3-B598-4CE1D848D95D Q28392241-2C7AD2C6-4CC7-44D1-8A78-C31AB5FCF907 Q28394334-43B0B816-D18B-4BDA-B74F-B310240E3410 Q28394465-98E6B17A-7814-4070-B014-7641E9E3F74A Q28395242-7D5F0744-4540-4C27-A428-685E51157889 Q28732760-2158DFE7-D0FA-4529-9482-42059CF49906 Q29248734-6269D5F1-2A95-41F1-9B14-BDEC46F628EB Q30253065-6163424B-7154-427B-9A02-511C31E060C2 Q30355471-25B1C3C4-E4AB-4F51-9232-B48D541E4DA8 Q30408059-876D7BC3-5641-4D1F-BA3A-9B387F6C60A3 Q30429577-297A87C2-8ADC-4A29-A710-E680B7755ABF Q30450624-F21CC9FC-5A05-4DE9-A932-324AECECB44E Q33563221-35DE19AB-EE0F-48BD-AEB4-4B4B3DB9D17D Q33585317-8A4DD031-C062-4A78-92CD-772E0403556D Q33598991-CBB6FB78-DB10-48A5-8FE2-7D3B4F2A6C32 Q33626486-6B68A534-4E15-4DE7-BD6E-7D6D28E33AFE Q33841883-402C3307-627B-44BA-B9BD-F54936CEB513 Q33901722-5BC9944C-620F-4D16-9D98-225B50091736 Q33998408-9A916AAB-78B4-4CA5-9060-87ADC8971A60 Q34134841-7F1F2FC4-B6A7-46AC-8F39-5A296B8BFCBC Q34143478-51C9C762-9C11-4190-967E-5A8CB4D3C0D5 Q34253499-5295074B-4FBD-459B-B129-370DF20AA379 Q34535086-1927BC36-DC38-4FE9-87B4-AD91B8D5F25F Q34540493-FA21DB73-E14A-498B-9E99-93E67ED717DA Q34572175-8C3AFFCE-A121-4D95-B54A-5B43FB000B21 Q34592341-E0F26B5E-636D-4A35-BC9B-9FA40F1433F4 Q34625223-A2502F12-0272-46FA-BAB0-CFB884A495A5

P2860

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

http://www.wikidata.org/entity/Q33921323

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@ast

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@en

type

label

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@ast

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@en

prefLabel

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@ast

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@en

P1433

Q33921323-E68E4CEC-641D-47CB-B43A-F7AE131FEBD8

P1476

Q33921323-456B8BAB-2617-4417-86A7-47BFA417D3D4

P2093

Q33921323-086DC036-4C99-420D-A2F5-C2FBE8F36950

Q33921323-1CE53D4C-AB75-4222-8757-479FEB7F96E4

Q33921323-2D49A258-C6DB-4BB9-8481-81438D5FCD83

Q33921323-687FE657-6333-46BB-80C8-032779F3AC05

Q33921323-6CBAA14C-203B-4598-B757-59512D2FAAD2

Q33921323-8BAF1D63-01CB-42FF-A7B4-62661CF68443

Q33921323-A27C4520-AF80-4D19-96C0-E9C6B00F801A

Q33921323-CB076139-01D5-42F1-A392-2CFA6EA1D5C7

Q33921323-D5A0C095-50F3-4F07-81F7-2204E2F90BDD

Q33921323-FB92C5D0-A065-4C22-91E2-D3915FED5009

P2860

Q33921323-00B4E45C-5329-44AD-BB77-009061A08C23

Q33921323-0C88D324-DFE1-4222-BF74-D391628515A4

Q33921323-14AA45BC-7D43-46E0-9757-9EE2F610002C

Q33921323-1AA71B96-A836-413C-A5F4-B832482E10D1

Q33921323-1ADC2C38-907C-4A93-A680-75205728F009

Q33921323-1F63D2FC-8829-4140-98FE-F34ECD112902

Q33921323-25393100-5903-4CE7-AF16-DE7DE6CC6897

Q33921323-2A17B57B-2B9C-4419-A938-61FF3138BFB1

Q33921323-2F958D1B-1484-4AA8-AEA3-89242BE1F3FD

Q33921323-440538BD-0095-4647-B0E1-592A1F7E33D3

P304

Q33921323-586304A6-7D66-426D-8805-19A22AB2E36E

P31

Q33921323-7D5E369B-2681-4A21-9A77-E52F1066446C

P356

Q33921323-AF757608-AE65-471B-97C3-AD8D70CA185C

P407

Q33921323-9341EE17-8A3A-45EE-8C78-80B5C5409BEF

P433

Q33921323-4FEB21FD-05E8-4E5C-9D4D-2D86181662B5

P478

Q33921323-DAF78560-DE8D-4216-848B-AA3CB55EF483

P50

Q33921323-0B825ED0-B7EA-4BA0-A885-84D3B382BE02

Q33921323-1FF8A35D-417E-4A0C-80DA-AA6BB03684B2

Q33921323-8A2E6A22-9154-448B-892A-7236F98C784C

P577

Q33921323-AD90DE19-4FC2-4B67-93FB-6E3C06331CB5

P698

Q33921323-FADE43E4-B607-477D-B4C5-3014F062C39D

P932

Q33921323-0B40D851-9D38-42D9-855A-3103581AE4DD

P356

P1433

The New England Journal of Medicine

P1476

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

@en

P2093

Eyal Shahar

http://www.w3.org/2001/XMLSchema#string

Firas S Ahmed

http://www.w3.org/2001/XMLSchema#string

J Jeffery Carr

http://www.w3.org/2001/XMLSchema#string

João A C Lima

http://www.w3.org/2001/XMLSchema#string

Karol E Watson

http://www.w3.org/2001/XMLSchema#string

Paul L Enright

http://www.w3.org/2001/XMLSchema#string

R Graham Barr

http://www.w3.org/2001/XMLSchema#string

Richard A Kronmal

http://www.w3.org/2001/XMLSchema#string

Rui Jiang

http://www.w3.org/2001/XMLSchema#string

Steven M Kawut

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Spirometric reference values from a sample of the general U.S. population

Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study

Standardisation of spirometry

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Multi-Ethnic Study of Atherosclerosis: objectives and design

Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis.

Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study.

Reproducibility and validity of lung density measures from cardiac CT Scans--The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.

Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.

P304

217-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0808836

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

362

http://www.w3.org/2001/XMLSchema#string

P50

David A. Bluemke

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20089972

http://www.w3.org/2001/XMLSchema#string

P932

2887729

http://www.w3.org/2001/XMLSchema#string